Publication | Closed Access

Assessing the Eligibility Criteria in Phase III Randomized Controlled Trials of Drug Therapy in Heart Failure With Preserved Ejection Fraction: The Critical Play-Off Between a “Pure” Patient Phenotype and the Generalizability of Trial Findings

Heart FailureCardiovascular DiseaseEligibility CriteriaClinical TrialsPharmacotherapyTrial FindingsCardiac CareDiuretic ResistanceDrug TrialMedicineCardiologyDiastolic FunctionEmergency Medicine